MSCLF
Satellos Bioscience Inc

111
Loading...
Loading...
Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. The company was founded by Frank Gleeson and Michael Rudnicki on July 27, 2012 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14

Frequently Asked Questions

What is Market Cap of Satellos Bioscience Inc?
What is the 52-week high for Satellos Bioscience Inc?
What is the 52-week low for Satellos Bioscience Inc?
What is Satellos Bioscience Inc stock price today?
What was Satellos Bioscience Inc stock price yesterday?
What is the PE ratio of Satellos Bioscience Inc?
What is the Price-to-Book ratio of Satellos Bioscience Inc?
What is the 50-day moving average of Satellos Bioscience Inc?
How many employess does Satellos Bioscience Inc has?

Latest MSCLF News

View
No MSCLF news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.